MEDIROM Healthcare Technologies Inc.
MRM · NASDAQ
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | -0.00 | 0.01 | -0.01 |
| FCF Yield | -22.12% | -131.96% | -24.16% | -2.31% |
| EV / EBITDA | -13.70 | 5.38 | -15.33 | 112.70 |
| Quality | ||||
| ROIC | -16.14% | 10.64% | -16.49% | -1.79% |
| Gross Margin | 10.83% | 34.61% | 16.59% | 24.82% |
| Cash Conversion Ratio | 0.51 | -0.76 | 1.35 | -0.05 |
| Growth | ||||
| Revenue 3-Year CAGR | 37.19% | 39.44% | 30.82% | 18.48% |
| Free Cash Flow Growth | 99.77% | -35.76% | -694.10% | 84.80% |
| Safety | ||||
| Net Debt / EBITDA | -9.67 | 4.38 | -7.77 | 50.30 |
| Interest Coverage | -32.22 | 0.00 | -30.87 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 16.07 | 20.80 | 18.09 | 19.25 |
| Cash Conversion Cycle | -20.83 | 12.73 | 16.99 | 30.90 |